국내에서 지역사회 급성 신우신염 원인균의 항균제 감수성 결과에 근거하여 지역사회 급성 방광염 치료 항균제를 선택할 수 있는가?
Is it Acceptable to Select Antibiotics for the Treatment of Community-acquired Acute Cystitis Based on the Antibiotics Susceptibility Results for Uropathogens from Community-acquired Acute Pyelonephritis in Korea?
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background: Uncomplicated acute cystitis (CA-UAC) is one of the most common infections treated with antibiotics in the community. However, few data on etiology of CA-UAC and its susceptibility to antibiotics are available, primarily because, in Korea, insurance does not allow reimbursement for microbiological evaluation of CA-UAC. However, microbiologic data on community-acquired uncomplicated acute pyelonephritis (CA-UAPN) are available. The objective of the study was to evaluate the question of whether microbiologic data on CA-UAPN can be used for treatment of CA-UAC; therefore, etiology and antimicrobial susceptibility were compared between pathogens of CA-UAC and those of CA-UAPN. Materials and Methods: During 2008, 538 CA-UACs and 1,265 CA-UAPNs were recruited retrospectively from 14 hospitals (UTI research group). Microbiologic data on etiology and susceptibility to antibiotics were collected retrospectively. Results: Urine culture was positive in 131 CA-UACs (131/469, 27.9%) and 719CA-UAPNs (719/1249, 57.6%). Escherichia coli was the most common pathogen in both groups [83.2% (109/131) in CA-UAC vs. 91.9% (661/719) in CA-UAPN]. Susceptibility to common UTI regimens, such as ciprofloxacin, extended-spectrum cephalosporins, and trimethoprim/sulfamethoxazole did not differ between urinary pathogens of CA-UACs and CA-UAPNs, however, a significant difference was observed in rates of resistance to ampicillin/sulbactam (16.5% vs. 42.9%, P<0.001,respectively). Conclusions: Rates of resistance of E. coli from CA-UAC and CA-UAPN to most antibiotics did not differ. For proper treatment, further microbiological evaluation for CA-UAC is mandatory.
Abstract
Background: Uncomplicated acute cystitis (CA-UAC) is one of the most common infections treated with antibiotics in the community. However, few data on etiology of CA-UAC and its susceptibility to antibiotics are available, primarily because, in Korea, insurance does not allow reimbursement for microbiological evaluation of CA-UAC. However, microbiologic data on community-acquired uncomplicated acute pyelonephritis (CA-UAPN) are available. The objective of the study was to evaluate the question of whether microbiologic data on CA-UAPN can be used for treatment of CA-UAC; therefore, etiology and antimicrobial susceptibility were compared between pathogens of CA-UAC and those of CA-UAPN. Materials and Methods: During 2008, 538 CA-UACs and 1,265 CA-UAPNs were recruited retrospectively from 14 hospitals (UTI research group). Microbiologic data on etiology and susceptibility to antibiotics were collected retrospectively. Results: Urine culture was positive in 131 CA-UACs (131/469, 27.9%) and 719CA-UAPNs (719/1249, 57.6%). Escherichia coli was the most common pathogen in both groups [83.2% (109/131) in CA-UAC vs. 91.9% (661/719) in CA-UAPN]. Susceptibility to common UTI regimens, such as ciprofloxacin, extended-spectrum cephalosporins, and trimethoprim/sulfamethoxazole did not differ between urinary pathogens of CA-UACs and CA-UAPNs, however, a significant difference was observed in rates of resistance to ampicillin/sulbactam (16.5% vs. 42.9%, P<0.001,respectively). Conclusions: Rates of resistance of E. coli from CA-UAC and CA-UAPN to most antibiotics did not differ. For proper treatment, further microbiological evaluation for CA-UAC is mandatory.
참고문헌 (20)
- Nicolle LE., "Urinary tract infection: traditional pharmacologic therapies", Am J Med, 113(Suppl 1A), pp.35S~44S (2002)
- Gupta K., "International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases", Clin Infect Dis, 52, pp.e103~e120 (2011)
- 대한감염학회, "요로 감염 임상진료지침 권고안: 무증상 세균뇨, 단순 요로감염, 복잡성 요로감염, 세균성 전립선염", Infection and Chemotherapy, 43(1), pp.1~25 (2011), 대한감염학회
- Hooton TM., "Diagnosis and treatment of uncomplicated urinary tract infection", Infect Dis Clin North Am, 11, pp.551~581 (1997)
- McNulty CA., "Clinical relevance of laboratory-reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care", J Antimicrob Chemother, 58, pp.1000~1008 (2006)
- Lee SS., "Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis", JOURNAL OF INFECTION, 62(2), pp.159~164 (2011), W B SAUNDERS CO LTD
- 황병연, "서울 강서지역 1개 대학병원에서 성인 급성 신우신염의 원인균과 항생제 감수성", Infection and Chemotherapy, 35(5), pp.277~282 (2003), 대한감염학회
- 위성헌, "2001년부터 2006년까지 지역사회 획득 급성 신우신장염 여성환자의 임상상 및 원인균의 내성 양상", Infection and Chemotherapy, 49(1), pp.9~16 (2007), 대한감염학회
- Wie SH., "Antibiotic sensitivity of the causative organisms and use of antibiotics in women with community-acquired acute pyelonephritis", Korean J Infect Dis, 34, pp.353~359 (2002)
- Karlowsky JA., "Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant : results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study", Antimicrob Agents Chemother, 50, pp.2251~2254 (2006)
- Shin J., "Fluoroquinolone Resistance in Uncomplicated Acute Pyelonephritis: Epidemiology and Clinical Impact", MICROBIAL DRUG RESISTANCE, 18(2), pp.169~175 (2012), MARY ANN LIEBERT INC
- Kim ME., "Prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: a multicentre study in 2006", Int J Antimicrob Agents, 31(Suppl 1), pp.S15~S18 (2008)
- Johnson DE., "Comparison of Escherichia coli strains recovered from human cystitis and pyelonephritis infections in transurethrally challenged mice", Infect Immun, 66, pp.3059~3065 (1998)
- Johnson JR., "Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women", J Clin Microbiol, 43, pp.6064~6072 (2005)
- Johnson JR., "Extended virulence genotypes and phylogenetic background of Escherichia coli isolates from patients with cystitis, pyelonephritis, or prostatitis", J Infect Dis, 191, pp.46~50 (2005)
- 김경영, "최근 2년간 전라남도 및 광주지역의 지역사회 획득성 요로감염에 이환된 여성 환자에서 동정된 Escherichia coli의 Ciprofloxacin 내성패턴", Korean Journal of Urology, 49(6), pp.540~548 (2008), 대한비뇨기과학회
- Paterson DL., "Extended-spectrum beta-lactamases : a clinical update", Clin Microbiol Rev, 18, pp.657~686 (2005)
- Lee SE., "A clinical study of oral fosfomycin(fosmycin)in the treatment of lower urinary tract infection", Korean J Urol, 25, pp.167~172 (1984)
- 유광호, "최근 요로감염증의 주요 원인균과 항생제 감수성에 관한 고찰", Korean Journal of Urology, 48(6), pp.638~645 (2007), 대한비뇨기과학회
- Lee YW., "Clinical efficacy of pivmecillinam(Selexid TM)in lower urinary tract infections", Korean J Urol, 24, pp.413~417 (1983)